Cannabis Oil for Pain Effectiveness

Trial Status: Recruiting
Start Date: July, 2018
Expected Enrolment: 40
Type of Trial: N/A
Protocol IDs: NCT03522467, OCOG-2017-COPE
Trial Design: Allocation: N/A
Trial Phase: Phase 2
Medical Conditions: Cancer, Chronic Pain
Drugs: MRCP001
Lead Sponsor: Aurora Cannabis Inc
Sponsors/Study Groups:
  • Ontario Clinical Oncology Group (OCOG)
  • Hamilton Health Sciences Corporation
Type of Treatment: None specified
Principal Investigator(s): Marissa Slaven, MD, Hamilton Health Sciences Corporation
Date posted on April 27, 2018
Last updated: June 7, 2020
This trial was imported from

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society